These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25084180)

  • 1. Stage-specific immune dysregulation in multiple sclerosis.
    Segal BM
    J Interferon Cytokine Res; 2014 Aug; 34(8):633-40. PubMed ID: 25084180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization.
    Weng Q; Wang J; Wang J; Wang J; Sattar F; Zhang Z; Zheng J; Xu Z; Zhao M; Liu X; Yang L; Hao G; Fang L; Lu QR; Yang B; He Q
    Cell Death Dis; 2018 Feb; 9(2):251. PubMed ID: 29445144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious versus protective autoimmunity in multiple sclerosis.
    Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
    Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
    Pierson E; Simmons SB; Castelli L; Goverman JM
    Immunol Rev; 2012 Jul; 248(1):205-15. PubMed ID: 22725963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation at single cell level: What is new?
    Brandão WN; De Oliveira MG; Andreoni RT; Nakaya H; Farias AS; Peron JPS
    J Leukoc Biol; 2020 Oct; 108(4):1129-1137. PubMed ID: 32779279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using EAE to better understand principles of immune function and autoimmune pathology.
    Rangachari M; Kuchroo VK
    J Autoimmun; 2013 Sep; 45():31-9. PubMed ID: 23849779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
    J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS.
    Dai H; Ciric B; Zhang GX; Rostami A
    Immunol Res; 2011 Dec; 51(2-3):145-52. PubMed ID: 22095543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
    Takada I; Yogiashi Y; Makishima M
    Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
    Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
    J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
    Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
    Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
    Chong WP; Horai R; Mattapallil MJ; Silver PB; Chen J; Zhou R; Sergeev Y; Villasmil R; Chan CC; Caspi RR
    J Autoimmun; 2014 May; 50():12-22. PubMed ID: 24021664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
    de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
    Front Immunol; 2020; 11():571844. PubMed ID: 33193354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.